Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer

Phase III studies have demonstrated the clinical benefit of adding neo-adjuvant androgen deprivation to radical radiotherapy for clinically localised prostate cancer. We have developed a nomogram to describe the probability of PSA control for patients treated in this way. Five hundred and seventeen...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, C C, Norman, A R, Huddart, R A, Horwich, A, Dearnaley, D P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375313/
https://www.ncbi.nlm.nih.gov/pubmed/11875726
http://dx.doi.org/10.1038/sj.bjc.6600160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375313/
https://www.ncbi.nlm.nih.gov/pubmed/11875726
http://dx.doi.org/10.1038/sj.bjc.6600160

Ejemplares similares